Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Free Cash Flow (2020 - 2025)

NeuroPace (NPCE) has 6 years of Free Cash Flow data on record, last reported at $415000.0 in Q4 2025.

  • For Q4 2025, Free Cash Flow rose 108.67% year-over-year to $415000.0; the TTM value through Dec 2025 reached -$11.3 million, up 37.92%, while the annual FY2025 figure was -$11.3 million, 37.92% up from the prior year.
  • Free Cash Flow reached $415000.0 in Q4 2025 per NPCE's latest filing, up from -$2.1 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $415000.0 in Q4 2025 and bottomed at -$11.7 million in Q1 2022.
  • Average Free Cash Flow over 5 years is -$5.6 million, with a median of -$5.4 million recorded in 2021.
  • Peak YoY movement for Free Cash Flow: plummeted 95.93% in 2022, then surged 108.67% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at -$8.5 million in 2021, then rose by 11.72% to -$7.5 million in 2022, then surged by 54.98% to -$3.4 million in 2023, then crashed by 41.95% to -$4.8 million in 2024, then soared by 108.67% to $415000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Free Cash Flow were $415000.0 in Q4 2025, -$2.1 million in Q3 2025, and -$2.1 million in Q2 2025.